Literature DB >> 22010866

The role of cost-effectiveness in U.S. vaccination policy.

Jane J Kim1.   

Abstract

Mesh：

Substances：

Year:  2011        PMID： 22010866     DOI： 10.1056/NEJMp1110539

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  11 in total

Review 1.  Do penalty-based pay-for-performance programs improve surgical care more effectively than other payment strategies? A systematic review.

Authors:  Kyung Mi Kim; Wendy Max; Justin S White; Susan A Chapman; Ulrike Muench
Journal:  Ann Med Surg (Lond)       Date:  2020-11-25

2.  Understanding FDA-Approved Labeling and CDC Recommendations for Use of Vaccines.

Authors:  H Cody Meissner; Karen Farizo; Douglas Pratt; Larry K Pickering; Amanda C Cohn
Journal:  Pediatrics       Date:  2018-09       Impact factor: 7.124

Review 3.  Economic evaluation of vaccines in Canada: A systematic review.

Authors:  Ayman Chit; Jason K H Lee; Minsup Shim; Van Hai Nguyen; Paul Grootendorst; Jianhong Wu; Robert Van Exan; Joanne M Langley
Journal:  Hum Vaccin Immunother       Date:  2016-02-18       Impact factor: 3.452

4.  Impact of vaccine herd-protection effects in cost-effectiveness analyses of childhood vaccinations. A quantitative comparative analysis.

Authors:  Marisa Holubar; Maria Christina Stavroulakis; Yvonne Maldonado; John P A Ioannidis; Despina Contopoulos-Ioannidis
Journal:  PLoS One       Date:  2017-03-01       Impact factor: 3.240

Review 5.  Natural history of human papillomavirus and vaccinations in men: A literature review.

Authors:  Benjamin J Lieblong; Brooke E E Montgomery; L Joseph Su; Mayumi Nakagawa
Journal:  Health Sci Rep       Date:  2019-03-12

6.  Pediatric Vaccines and Cost-Effectiveness Thresholds: How Much is Too Much to Pay for Prevention?

Authors:  Jordan Amdahl; Derek Weycker; Ray Farkouh; Liping Huang; Caitlin Eichten; Gerry Oster
Journal:  Infect Dis Ther       Date:  2020-11-10

7.  Estimation of the cost-effective threshold of a quality-adjusted life year in China based on the value of statistical life.

Authors:  Dan Cai; Si Shi; Shan Jiang; Lei Si; Jing Wu; Yawen Jiang
Journal:  Eur J Health Econ       Date:  2021-10-16

8.  Size of clinical trials and Introductory prices of prophylactic vaccine series.

Authors:  Steven H Weinberg; Amy T Butchart; Matthew M Davis
Journal:  Hum Vaccin Immunother       Date:  2012-08-01       Impact factor: 3.452

Review 9.  The use of expensive technologies instead of simple, sound and effective lifestyle interventions: a perpetual delusion.

Authors:  Silvia Carlos; Jokin de Irala; Matt Hanley; Miguel Ángel Martínez-González
Journal:  J Epidemiol Community Health       Date:  2014-06-24       Impact factor: 3.710

10.  COVID-19 Vaccines Cost-Effectiveness Analysis: A Scenario for Iran.

Authors:  Atefeh Vaezi; Alipasha Meysamie
Journal:  Vaccines (Basel)       Date:  2021-12-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.